Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study

Table 1 Demographic and substance use profile of participants (N = 22)

	N (%)/Mean ± SD
Demographic characteristics
Gender
Man	14 (63.6)
Woman	8 (36.4)
Age, years	40 ± 11.0
Self-reported indigenous ancestry
First Nations	5 (22.7)
Métis	6 (27.3)
No	11 (50.0)
Health Authority of residence
Fraser	5 (21.7)
Interior	4 (17.4)
Island	4 (17.4)
Northern	5 (21.7)
Vancouver Coastal	4 (17.4)
Housing
Private residence	4 (18.2)
Other housing	14 (63.6)
No regular place to stay	4 (18.2)
Employed
Yes	8 (36.4)
No	14 (63.6)
Substance use characteristics
Years of illicit drug use	24 ± 10.9
Years of MA use	11 ± 8.1
Preferred route of administration for any substance use
Smoking	10 (45.5)
Injecting	9 (40.9)
Snorting	2 (9.1)
Smoking and injecting	1 (4.5)
Frequency of MA use
Daily	16 (72.7)
Often (not defined)	1 (4.5)
Few times a week	3 (13.6)
Few times a month	1 (4.5)
Once a month or less	1 (4.5)
Use alone
Never	1 (4.5)
Rarely	1 (4.5)
Occasionally	5 (22.7)
Often	9 (40.9)
Always	6 (27.3)
Opioid overdose in last 3 months
Yes	6 (27.3)
No	16 (72.7)

MA, methamphetamine; Indigenous ancestry included option of First Nations, Métis, Inuit, or no Indigenous ancestry. No participants self-reported Inuit ancestry. Gender response options were man, woman, transgender man, transgender woman, or gender expansive
No participants identified as transgender or gender expansive (including people who identified as transgender men, transgender women, or gender non-confirming people)

ISSN: 1477-7517